Every year, nearly 900,000 Americans are affected by venous thromboembolism (VTE), a condition in which blood clots form in ...

It wasn’t a musculoskeletal injury, it was a blood clot. It turned out that Culler was a carrier of Factor V Leiden, a ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

It may not come as a surprise to learn that boarding a long-haul flight is not the best thing we can do for our bodies. Being ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

Fighting back is relatively simple. It involves staying active and keeping the blood flowing.

For more than a century, heparin has been the go-to anticoagulant to prevent harmful blood clots in blood vessels or the ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs ...

Hudson Reid, 2, spent four weeks in hospital after a sickness bug developed into a "one in a billion" illness.

Pulmonary embolisms occur when blood clots form elsewhere in the body and travel to the lungs, where they can become ...

New guidelines from the American Heart Association and ACC warn that pulmonary embolism, a sudden lung artery blockage, can ...

Discover the molecular mechanisms behind severe blood clots linked to specific COVID-19 vaccines, revealing crucial insights for future vaccine safety.